Vitamin D receptor gene polymorphisms and cardio-metabolic profile in women with hypovitaminosis D
-
Samira Ebrahimof
,
Sakineh Shab-bidar
,
Marjan Zarif Yeganeh
,
Pooneh Angoorani
,
Somayeh Abedini
,
Farzaneh Jahangir
,
Maryam-Sadat Daneshpour
,
Mehdi Hedayati
Abstract
Objective: The possible role of vitamin D receptor (VDR) variants in determining cardiovascular risk factors has been suggested previously. The purpose of the present study was to evaluate the associations of variants of vitamin D receptor (VDR) gene with metabolic profile in Iranian overweight women with hypovitaminosis D.
Materials and Methods: Variants in VDR gene including FokI (rs2228570), BsmI (rs1544410) and rs757343 were detected using PCR-sequencing. Metabolic Profile including fasting plasma glucose, total cholesterol, LDL-C, HDL-C, and triacylglycerol was assessed using commercial kits. Circulating 25 (OH) D was measured using ELISA kits. Fat mass and visceral fat were measured using Bio Impedance Analysis.
Results: A sample of 123 overweight women with hypovitaminosis D (25 (OH) D<75nmol/L) was studied. The mean 25 (OH) D level was 28.7±17.0nmol/L. The FokI polymorphism was significantly associated with total cholesterol (p=0.03) and LDL-C (p=0.01). Carriers of the CC genotype of the FokI polymorphism had lower total cholesterol (162.9±30.4 vs. 176.1±32.4, p=0. 02) and LDL-C (98.0±26.0 vs. 110.6±28.5, p=0. 01) compared with carriers of CT+TT genotype. Regression analysis revealed that the FokI variant and fat mass explained 18% of the variance in total cholesterol. Regarding LDL-C, FokI variant explained 21% of the variance in LDL-C. None of the studied polymorphisms were significantly associated with adiposity phenotypes (p>0.05). Also, adiposity phenotype measures were not significantly different in the genotype groups of the studied SNPs (p>0.5).
Conclusions: The present results indicate that the FokI polymorphism is significantly associated with total cholesterol and LDL-C in Iranian overweight women with hypovitaminosis D.
Holick MF. Vitamin D deficiency. The New England journal of medicine. 2007;357(3):266-81.
Moradzadeh M, Larijani B, Keshtkar AA, Hossein-Nezhad A, Rajabian R, Nabipour I, et al. Normative Values of Vitamin D Among Iranian Population: A Population Based Study. International Journal of Osteoporosis and Metabolic Disorders, 1: 8-15. Int J Osteo Metab. 2008;1:8-15.
Alipour S, Saberi A, Seifollahi A, Shirzad N, Hosseini L. Risk factors and prevalence of vitamin d deficiency among Iranian women attending two university hospitals. Iranian Red Crescent medical journal. 2014;16(10):e15461.
Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. Journal of health, population, and nutrition. 2011;29(2):149-55.
Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clinic proceedings. 2013;88(7):720-55.
Holick MF. Vitamin D: extraskeletal health. Rheumatic diseases clinics of North America. 2012;38(1):141-60.
Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS medicine. 2013;10(2):e1001383.
Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. The Journal of clinical endocrinology and metabolism. 2004;89(3):1196-9.
Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcified tissue international. 1988;43(4):199-201.
Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. Journal of endocrinological investigation. 2007;30(8):653-8.
Palacios C, Gil K, Perez CM, Joshipura K. Determinants of vitamin D status among overweight and obese Puerto Rican adults. Annals of nutrition & metabolism. 2012;60(1):35-43.
Caron-Jobin M, Morisset AS, Tremblay A, Huot C, Legare D, Tchernof A. Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring). 2011;19(7):1335-41.
Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A. Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Current vascular pharmacology. 2010;8(5):720-30.
vinh quoc Lu'o'ng K, Nguyen LT. The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutrition journal. 2013;12:89.
Weber K, Erben RG. Differences in triglyceride and cholesterol metabolism and resistance to obesity in male and female vitamin D receptor knockout mice. Journal of animal physiology and animal nutrition. 2013;97(4):675-83.
Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009;150(2):651-61.
Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. The aging male : the official journal of the International Society for the Study of the Aging Male. 2008;11(3):134-9.
Schuch NJ, Garcia VC, Vivolo SR, Martini LA. Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome. Nutrition journal. 2013;12:96.
Soroush N, Radfar M, Hamidi AK, Abdollahi M, Qorbani M, Razi F, et al. Vitamin D receptor gene FokI variant in diabetic foot ulcer and its relation with oxidative stress. Gene. 2017;599:87-91.
Maia J, da Silva AS, do Carmo RF, de Mendonca TF, Griz LH, Moura P, et al. The association between vitamin D receptor gene polymorphisms (TaqI and FokI), Type 2 diabetes, and micro-/macrovascular complications in postmenopausal women. The application of clinical genetics. 2016;9:131-6.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Medicine and science in sports and exercise. 2003;35(8):1381-95.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research. 1988;16(3):1215.
Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. European journal of endocrinology / European Federation of Endocrine Societies. 2001;145(2):181-6.
Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes & metabolism. 2005;31(4 Pt 1):318-25.
Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. The British journal of nutrition. 2012;108(11):1915-23.
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143-56.
Colombini A, Brayda-Bruno M, Lombardi G, Croiset SJ, Vrech V, Maione V, et al. FokI Polymorphism in the Vitamin D Receptor Gene (VDR) and Its Association with Lumbar Spine Pathologies in the Italian Population: A Case-Control Study. PloS one. 2014;9(5):e97027.
Moreno Lima R, Silva de Abreu B, Gentil P, Cesar de Lima Lins T, Grattapaglia D, Pereira RW, et al. Lack of association between vitamin D receptor genotypes and haplotypes with fat-free mass in postmenopausal Brazilian women. The journals of gerontology Series A, Biological sciences and medical sciences. 2007;62(9):966-72.
Ochs-Balcom HM, Chennamaneni R, Millen AE, Shields PG, Marian C, Trevisan M, et al. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. The American journal of clinical nutrition. 2011;93(1):5-10.
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clinica chimica acta; international journal of clinical chemistry. 2006;371(1-2):1-12.
Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. European journal of endocrinology / European Federation of Endocrine Societies. 2004;150(3):323-8.
Tworowska-Bardzinska U, Lwow F, Kubicka E, Laczmanski L, Jedzrzejuk D, Dunajska K, et al. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2008;24(9):514-8.
Beydoun MA, Tanaka T, Beydoun HA, Ding EL, Ferrucci L, Zonderman AB. Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults. Journal of nutritional science. 2013;2:e33.
Mackawy AM, Badawi ME. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta gene. 2014;2:540-56.
Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochemical and biophysical research communications. 2015;456(2):631-6.
Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2000;14(9):1132-8.
Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ. The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biological & pharmaceutical bulletin. 2005;28(8):1418-23.
Kamycheva E, Jorde R, Figenschau Y, Haug E. Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. Journal of endocrinological investigation. 2007;30(2):126-32.
Chow EC, Magomedova L, Quach HP, Patel R, Durk MR, Fan J, et al. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. Gastroenterology. 2014;146(4):1048-59.
| Files | ||
| Issue | Vol 2, No 2 (Spring 2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Hypovitaminosis D Metabolic profile Total cholesterol LDL-C VDR variants Overweight | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
